Ernst Reichmann Selected Research

Artificial Skin

1/2022	Bioprinting and plastic compression of large pigmented and vascularized human dermo-epidermal skin substitutes by means of a new robotic platform.
1/2021	Mechanical stimulation induces rapid fibroblast proliferation and accelerates the early maturation of human skin substitutes.
1/2019	Induction of angiogenic and inflammation-associated dermal biomarkers following acute UVB exposure on bio-engineered pigmented dermo-epidermal skin substitutes in vivo.
2/2018	Characterization of M1 and M2 polarization of macrophages in vascularized human dermo-epidermal skin substitutes in vivo.
11/2017	The Effect of Wound Dressings on a Bio-Engineered Human Dermo-Epidermal Skin Substitute in a Rat Model.
5/2017	Evaluation of cultured human dermal- and dermo-epidermal substitutes focusing on extracellular matrix components: Comparison of protein and RNA analysis.
3/2015	The influence of stromal cells on the pigmentation of tissue-engineered dermo-epidermal skin grafts.
1/2015	Long-term expression pattern of melanocyte markers in light- and dark-pigmented dermo-epidermal cultured human skin substitutes.
12/2014	Differential expression of granulocyte, macrophage, and hypoxia markers during early and late wound healing stages following transplantation of tissue-engineered skin substitutes of human origin.
3/2013	"Trooping the color": restoring the original donor skin color by addition of melanocytes to bioengineered skin analogs.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ernst Reichmann Research Topics

Disease

10	Wounds and Injuries (Trauma) 01/2021 - 03/2013
6	Burns 01/2022 - 03/2011
6	Neoplasms (Cancer) 12/2017 - 01/2002
4	Melanoma (Melanoma, Malignant) 01/2018 - 01/2012
3	Cicatrix (Scar) 05/2017 - 06/2010
2	Inflammation (Inflammations) 01/2019 - 01/2018
2	Hypoxia (Hypoxemia) 12/2014 - 01/2002
1	Spinal Dysraphism (Spina Bifida) 01/2020
1	Skin Neoplasms (Skin Cancer) 01/2018
1	Virus Diseases (Viral Diseases) 01/2018
1	Infections 11/2017
1	Rare Diseases (Rare Disease) 09/2016
1	Inguinal Hernia (Direct Inguinal Hernia) 01/2016
1	Neoplasm Metastasis (Metastasis) 03/2011
1	Breast Neoplasms (Breast Cancer) 03/2011

Drug/Important Bio-Agent (IBA)

3	HydrogelsIBA 01/2018 - 05/2013
3	PlasticsIBA 06/2014 - 03/2011
2	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 01/2018 - 12/2017
2	Adapalene (Differin)FDA LinkGeneric 01/2018 - 12/2017
2	Biological ProductsIBA 01/2016 - 08/2002
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	InflammasomesIBA 01/2018
1	Dihydrotachysterol (AT 10)IBA 11/2017
1	CollagenIBA 01/2016
1	Biocompatible Materials (Biomaterials)IBA 01/2016
1	PolymersIBA 01/2016
1	Oxygen (Dioxygen)IBA 06/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2014
1	matridermIBA 05/2013
1	Collagen Type I (Type I Collagen)IBA 05/2013
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 03/2011
1	Protein Isoforms (Isoforms)IBA 03/2011
1	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2011
1	IntegrinsIBA 03/2005
1	Fas Ligand Protein (Fas Ligand)IBA 08/2002
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2002
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2002
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2002
1	Oncogene Proteins (Oncogene Protein)IBA 01/2002
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2002

Therapy/Procedure

12	Artificial Skin 01/2022 - 06/2010
5	Transplantation 01/2020 - 01/2012
1	Skin Transplantation (Skin Grafting) 01/2021
1	Precision Medicine 09/2016
1	Therapeutics 01/2012